Business Description
Brain+ AS
ISIN : DK0061670205
Compare
Compare
Traded in other countries / regions
BRAINP.Denmark0SY.Germany IPO Date
2021-10-07Description
Brain+ AS is a digital therapeutics company. It restores patients' quality of life by treating and detecting a cognitive decline in Alzheimer's disease and dementia through digital means. It has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI).
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.45 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -75 | |||||
| 3-Year EPS without NRI Growth Rate | -82.9 | |||||
| 3-Year Book Growth Rate | 56.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.79 | |||||
| 9-Day RSI | 25.48 | |||||
| 14-Day RSI | 30.49 | |||||
| 6-1 Month Momentum % | -25.07 | |||||
| 12-1 Month Momentum % | -84.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.02 | |||||
| Quick Ratio | 6.02 | |||||
| Cash Ratio | 4.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10 | |||||
| Shareholder Yield % | -111.09 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -65.75 | |||||
| ROA % | -26.6 | |||||
| ROIC % | -25.66 | |||||
| ROC (Joel Greenblatt) % | -4160.71 | |||||
| ROCE % | -37.02 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.2 | |||||
| EV-to-EBIT | -0.17 | |||||
| EV-to-EBITDA | -0.23 | |||||
| EV-to-FCF | -0.42 | |||||
| Earnings Yield (Greenblatt) % | -578.06 | |||||
| FCF Yield % | -148.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Brain+ AS Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.536 | ||
| Beta | 0 | ||
| Volatility % | 85.86 | ||
| 14-Day RSI | 30.49 | ||
| 14-Day ATR (kr) | 0.018625 | ||
| 20-Day SMA (kr) | 0.125175 | ||
| 12-1 Month Momentum % | -84.47 | ||
| 52-Week Range (kr) | 0.0726 - 0.95 | ||
| Shares Outstanding (Mil) | 91.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Brain+ AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Brain+ AS Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Brain+ AS Frequently Asked Questions
What is Brain+ AS(OCSE:BRAINP)'s stock price today?
The current price of OCSE:BRAINP is kr0.09. The 52 week high of OCSE:BRAINP is kr0.95 and 52 week low is kr0.07.
When is next earnings date of Brain+ AS(OCSE:BRAINP)?
The next earnings date of Brain+ AS(OCSE:BRAINP) is 2024-05-10 Est..
Does Brain+ AS(OCSE:BRAINP) pay dividends? If so, how much?
Brain+ AS(OCSE:BRAINP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers